ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
Efficacy of fulvestrant and capecitabine as maintenance therapy in patients with HR +/HER2 - metastatic breast cancer benefited from first-line chemotherapy.
Qing Liu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.